Neil Rotherham is a serial entrepreneur with over 25 year’s experience in the pharmaceutical and medical technology markets with proven experience of running and building businesses in the UK and USA. Neil, now Chairman at organisations including BOB.health and Raremark, as well as Non-Executive Director at Greenphire and Imagen Therapeutics, shares his view on the impact of Covid-19 on the pharmaceutical technology sector in the short to long term.

For more information on Neil Rotherham, please click here.

Listen to the Podcast below: